• 698 Posts
  • 966 Comments
Joined 3 years ago
cake
Cake day: June 1st, 2023

help-circle














  • That’s been the term of choice in English for the past 800+ years

    In English, the word “milk” has been used to refer to “milk-like plant juices” since 1200 CE.[11]

    Plant milks go back much further than most people realize

    Almond milk spread throughout Europe during the Middle Ages and was popular in parts of the Middle East. Recipes for almond milk in the Middle East date back to around the 13th century as it was mentioned in Muhammad bin Hasan al-Baghdadi’s cookbook Kitāb al-Ṭabīḫ (كتاب الطبيخ; The Book of Dishes), written in 1226. It was especially popular during Lent.[12][13][14][15] Soy was a plant milk used in China during the 14th century.[3][16] Soy milk use in China is first recorded in 1365.[17] In medieval England, almond milk was used in dishes such as ris alkere (a type of rice pudding)[18] and appears in the recipe collection The Forme of Cury.[19] Coconut milk (and coconut cream) are traditional ingredients in many cuisines such as in South and Southeast Asia, and are often used in curries.[20]

    https://en.wikipedia.org/wiki/Plant_milk



















  • I suggest read the original study instead of a paper’s interpretation of it. They suggest action, and that’s changing the suggested inhalers people use in most cases. It’s not “blame people for thing”, it’s “here’s a problem and how we can dramatically reduce it with some minor systemic changes”

    All but 2 therapeutic classes (short-acting muscarinic antagonists and ICS-SABAs) had dry powder and/or soft mist inhalers available. If patients during the study period had received the inhalers with the lowest emissions intensity available at the time in each therapeutic class, total emissions would have decreased by 92%, from 24.9 million mtCO2e to 2.1 million mtCO2e (eTable 6 in Supplement 1).

    […]

    This study identifies a high ceiling for potential climate-related gains from switching patients to therapeutically equivalent alternatives. Any such efforts to shift prescribing will likely depend on broadscale formulary changes—and the policies required to incentivize such changes—rather than just individual actions by patients and physicians, who may be limited by payer formularies when choosing particular inhalers

    https://jamanetwork.com/journals/jama/fullarticle/2839471